Hydralazine injection labels and packages: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 41: Line 41:


{|
{|
| [[image:hydra10.png|400px|thummb]]
| [[image:hydra10.jpg|400px|thumb]]
|}
|}



Revision as of 06:35, 11 March 2014

Hydralazine
HYDRALAZINE tablet® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Labels and Packages
HYDRALAZINE injection® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Labels and Packages
Clinical Trials on Hydralazine
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]

PACKAGE LABEL - PRINCIPAL DISPLAY - Hydralazine Hydrochloride 1 mL Single Dose Vial Label

NDC 63323-614-55

NP601401

hydrALAZINE HYDROCHLORIDE INJECTION, USP 20 mg/mL

FOR IM OR IV USE

1 mL Rx only

Single Dose Vial WARNING: DISCARD UNUSED PORTION.

PACKAGE LABEL - PRINCIPAL DISPLAY - Hydralazine Hydrochloride 1 mL Single Dose Vial Tray Label NDC 63323-614-55

NP601401

hydrALAZINE HYDROCHLORIDE INJECTION, USP

FOR INTRAMUSCULAR OR INTRAVENOUS USE

20 mg/mL

1 mL Single Dose Vial

N+ and NOVAPLUS are registered trademarks of Novation, LLC

Rx only

[1]


References

  1. "HYDRALAZINE HYDROCHLORIDE INJECTION [FRESENIUS KABI USA, LLC]". Retrieved 10 March 2014.